Suppression of phosphatidylinositol 3-kinase/Akt signaling pathway is a determinant of the sensitivity to a novel histone deacetylase inhibitor, FK228, in lung adenocarcinoma cells. (Q45261602)
Jump to navigation
Jump to search
scientific article published in March 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Suppression of phosphatidylinositol 3-kinase/Akt signaling pathway is a determinant of the sensitivity to a novel histone deacetylase inhibitor, FK228, in lung adenocarcinoma cells. |
scientific article published in March 2005 |
Statements
Suppression of phosphatidylinositol 3-kinase/Akt signaling pathway is a determinant of the sensitivity to a novel histone deacetylase inhibitor, FK228, in lung adenocarcinoma cells (English)
Masahiro Kodani
Tadashi Igishi
Shingo Matsumoto
Hiroki Chikumi
Yasushi Shigeoka
Hirofumi Nakanishi
Masato Morita
Kazuhito Yasuda
Yutaka Hitsuda